Filing Details
- Accession Number:
- 0000921895-22-002856
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-10-27 17:24:21
- Reporting Period:
- 2022-10-25
- Accepted Time:
- 2022-10-27 17:24:21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
707388 | Star Equity Holdings Inc. | STRR | Electromedical & Electrotherapeutic Apparatus (3845) | 330145723 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1548312 | E. Jeffrey Eberwein | C/O Star Equity Holdings, Inc. 53 Forest Avenue, Suite 101 Old Greenwich CT 06870 | Executive Chairman | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-10-25 | 9,250 | $1.00 | 2,699,969 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-26 | 7,000 | $1.01 | 2,706,969 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-27 | 3,200 | $1.01 | 2,710,169 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
10% Series A Cumulative Perpetual Preferred Stock | 1,243,422 | Direct |
Footnotes
- The purchases of the shares reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Eberwein.
- The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $0.97 to $1.01, rounded to the nearest cent, inclusive. Mr. Eberwein undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.